Literature DB >> 8798779

Murine alpha-macroglobulins demonstrate divergent activities as neutralizers of transforming growth factor-beta and as inducers of nitric oxide synthesis. A possible mechanism for the endotoxin insensitivity of the alpha2-macroglobulin gene knock-out mouse.

D J Webb1, J Wen, J J Lysiak, L Umans, F Van Leuven, S L Gonias.   

Abstract

alpha2-Macroglobulin null mice demonstrate increased resistance to endotoxin challenge (Umans, L., Serneels, L., Overbergh, L., Van Leuven, F., and Van den Berghe, H. (1995) J. Biol. Chem. 270, 19778-19785). We hypothesized that this phenotype might reflect the function of murine alpha2M (malpha2M) as a neutralizer of transforming growth factor-beta (TGF-beta) and inducer of nitric oxide synthesis in vivo. When incubated with wild-type mouse plasma, TGF-beta1 and TGF-beta2 bound only to malpha2M. Alternative TGF-beta-binding proteins were not detected in plasma from alpha2M(-/-) mice. Wild-type mouse plasma, but not plasma from alpha2M(-/-) mice, inhibited TGF-beta1 binding to TGF-beta receptors on fibroblasts. Purified malpha2M bound TGF-beta1 and TGF-beta2 with similar affinity; the KD values were 28 +/- 4 and 33 +/- 4 nM, respectively. Murinoglobulin, the second murine alpha-macroglobulin, bound both TGF-beta isoforms with 30-fold lower affinity. Malpha2M counteracted the activities of TGF-beta1 and TGF-beta2 in an endothelial cell growth assay. Malpha2M also induced NO synthesis when incubated with RAW 264.7 cells, an activity which probably results from the neutralization of autocrine TGF-beta activity. Human alpha2M induced NO synthesis comparably to malpha2M; however, MUG had no effect. These studies demonstrate that the ability to neutralize TGF-beta is a property of malpha2M, which is not redundant in the murine alpha-macroglobulin family or in murine plasma. Malpha2M is the only murine alpha-macroglobulin that promotes NO synthesis. The absence of malpha2M, in alpha2M(-/-) mice, may allow TGF-beta to more efficiently suppress excessive iNOS expression following endotoxin challenge.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798779     DOI: 10.1074/jbc.271.40.24982

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB.

Authors:  D J Webb; D W Roadcap; A Dhakephalkar; S L Gonias
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis.

Authors:  L Umans; L Serneels; L Overbergh; L Stas; F Van Leuven
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

3.  Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide.

Authors:  A Morikawa; N Koide; Y Kato; T Sugiyama; D Chakravortty; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Application of on-line nanoLC-IT-TOF in the identification of serum β-catenin complex in mice scald model.

Authors:  Cheng-cai Huang; Shi-hai Yan; Dan Chen; Bi-cheng Chen; Ning-wei Zhao
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

5.  Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.

Authors:  Stacey D Finley; Manjima Dhar; Aleksander S Popel
Journal:  Front Oncol       Date:  2013-07-30       Impact factor: 6.244

6.  Transforming growth factor beta production is inversely correlated with severity of murine malaria infection.

Authors:  F M Omer; E M Riley
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.